Noninvasive Assessment of Tumor VEGF Receptors in Response to Treatment with Pazopanib: A Molecular Imaging Study
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference43 articles.
1. Predicting benefit from antiangiogenic agents in malignancy;Jubb;Nat Rev Cancer,2006
2. Cutting off cancer's supply lines;Hayden;Nature,2009
3. Antiangiogenic therapy: creating a unique “window” of opportunity;Lin;Cancer Cell,2004
4. Lessons from phase III clinical trials on anti-VEGF therapy for cancer;Jain;Nat Clin Pract Oncol,2006
5. Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology: tools or decorations?;Sessa;Nat Clin Pract Oncol,2008
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Role of VEGF Receptors as Molecular Target in Nuclear Medicine for Cancer Diagnosis and Combination Therapy;Cancers;2021-03-03
2. Computed Tomography and Magnetic Resonance Imaging;Molecular Imaging in Oncology;2020
3. A Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance);The Oncologist;2019-12-24
4. Radiolabeling of VEGF165 with 99mTc to evaluate VEGFR expression in tumor angiogenesis;International Journal of Oncology;2017-05-08
5. Pazopanib;Adverse Events and Oncotargeted Kinase Inhibitors;2017
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3